{"name":"Biomica Ltd.","slug":"biomica-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BMC128","genericName":"BMC128","slug":"bmc128","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"BMC128","genericName":"BMC128","slug":"bmc128","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxNQWYwbGQtWnN1TmNuZDYxN0lySS1NSGFzU2pPT3VlangtdnloUnhrUDZsRk5ZSGFNVnhmdm01bmhUMDJCTkpkZXUwNmkxQWREWUk0TFowOWpjQmRXd0R1ajYzX1MzOU5ZUmdHbmdjSU9KVlNpNjdBUDFKbWtvODNPN3JRZXoxUllRN0daSWVxVzhWbmpHaUp6bkxRY3MzY2tWSzlFRjd0ZktuU2sxWTk5SkVCZkpSa0ROeGhKSzdNQnZVdzJxMG1sVWs4MVMxVEU3YzZ4c3RpMFFzYkhGTjh5d1VGRXZ1NFVSTjZjcGkxM3JCeEU4SnpuTnlGaWpqNEFtZFVFSkdnalJkTGI0djluU2xFSDNkTDVKUmVkQXpHSmluVXJIeW01YTdZVWtFaVpTRFY4WEVoYUtHRWc?oc=5","date":"2026-02-04","type":"pipeline","source":"PR Newswire","summary":"Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer - PR Newswire","headline":"Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxQbDJOV0Z6QUNOY04zRllBZTRJSG5pNEtTZGkwVjk3SDlYc0F3dkFEdjI0TmcwNmplSFc2YUozM3pzekF4SWthU2YyWUJCVHhTNUpIaTN5Y1llSnRZbkZwam9SUWFPekM0RE1EVVBmMThLTU00RHViUmVILVNxTkVCa3NFYXoyTnhtZ1BlUk9UUnZwbjlfaTJwU2ptZUViRnBrS0VxWU9uQlRvOGtQb2ZQd0FLZGNfS0p5OE1mUUc1QmpaaFZTc0hhdTBJbGFaTkU?oc=5","date":"2026-02-04","type":"deal","source":"Contract Pharma","summary":"Biomica and Lishan Biotech Ink License Agreement for Microbiome-Based Cancer Therapeutic - Contract Pharma","headline":"Biomica and Lishan Biotech Ink License Agreement for Microbiome-Based Cancer Therapeutic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxNVTZIeGc2RVBHX2c1LXRrRHNvV0o3S3E1RzlPNFFiU2FCcEFfdkVDWFBBZGNlWnJWZ0dxNnZtUzg1R0VSejhEdTY3WmZOZmZWNkVxUDZpZXQyLVpiSmE2aGV3N0FmTy1Fc2M2djhTdTNHTW0zVkQySlV2WTAxRFZqQnlJdHFHc1g0MWtSN09lZkttR2xmbjBMOTlsRmljcldvUndzZ3M0LVVpT042UVZ1YjhES3RXOXRaUFJMUk1kVHE2bmtHMWx3Zko1S2h2NDlhd3lGSEd6eUV2TXJLVzhIXzhoVVdBc1BOZExOLU5Wa0V5X0FZd3NEVzFkSTk3a1RyTTNUbTFmZVVIX3JYMklrSkdRcXFHb21zbVBqS0hVWmlBaFdY?oc=5","date":"2025-06-10","type":"deal","source":"PR Newswire","summary":"Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud - PR Newswire","headline":"Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaborati","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AJBVV95cUxNQ2ZFTnJ5OW1iRGRUcjlSVnpqdTZIeWVPTTA2cDJvX1VjM0xmOXgzV1NuLTV5bUY5RERRM25IX3hadk5NaHpzckttT21pYTI5RFZSVkxmSVFtSG1Pb3JWWUdrLXpQM24wbGtSTko0ZHpIM1BnYlpPXzE2MGx1RWxnU1dIYl9oTHdmTUNra3NEYjdfazY1al9BUk1pY2lxZHdKZTB4bDlJNS1BMWF2ODdkQ2U4M3NMQmp3bjB3MzdfVzFUbS1yZ3hPSkZqcWc2TFI3U2Z6engtUTRIMDhUbUhvQi1rTXhmS1FqVWlKTVZiNlF5U0h5dUJtcXhMY2txd1hfWFV6WGc4WUFOSDhQaGtIQUlhYWpUYWx3SWpyY3cyVENHSlEzcnZ6Y1dRVGF3TV9mcGk4RUV6UVY5NmtGNDVpR1RMeVFjNzRkcWQteTNINHQ4WFZ6?oc=5","date":"2025-01-28","type":"regulatory","source":"Barchart.com","summary":"Irritable Bowel Syndrome Pipeline 2024: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | P4 Microbiome, Biomica, Invea Therapeutics, RaQualia Pharma, RedHill Bio ","headline":"Irritable Bowel Syndrome Pipeline 2024: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveIns","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE1MSWlLTV9sOFUxZjVZX1JwbUh3dUwwX0RHQk0tOWtBSzBzTnRGT3F5YlNOVmVnQ2UxMnBQZ0RPZU9acVJTcVNZYzF4c0U3RmpILXJsV1pZRm9UV0xIRG8zdkRDSHZSUzB6X28tbTJJX0xYTWo2OEE?oc=5","date":"2024-03-12","type":"pipeline","source":"pharmaphorum","summary":"Why gut bacteria is the next frontier in medicine - pharmaphorum","headline":"Why gut bacteria is the next frontier in medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOUUdJdEdXMkh4V1NEaVhKdVZveWdJSTdKTVQ1NHFCa281STlsMzZicGhhSjB2UW5US3R1U0M2MGZtQ1lwb3NIdm1Oclo0UTFKaVMzX0h1VUpTZUF2WUVQV2U4SDB3bmM1N2NQekV0bDFrTXVJTzNmcGdLR2NBeWc1T1FSaTRjQVZzdWZ4NjBSOFFoTDVwekFjU205U1JlekpaUk94RkZLaFJXcVo0MC04SWVabmJFaERoT3BJOG5vdw?oc=5","date":"2024-01-17","type":"trial","source":"BioSpace","summary":"Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug - BioSpace","headline":"Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOemZkTFJ3SllQcWJGZEI1Vm92RHVhYUl4TV9NdzU2MGRSNDFnUEI5bkF3VlZ1SkttT3dETmViRXhnb1VjWEhNTEotaldISU44THJPcElfOVF4TFk1LVVhQk55VlZpelNUbVRNNGt0VlBrRlpZMWN3V0xObzh0TVhHMGs3V0x4N24wU2xMYk9ZOW5ROGh2NmVaZG5WTXd2MFRZb1B1aHp5T3Y1Y29VMWFfRjE3Y19wRnhGYUZVTUVjT0tzUFNY?oc=5","date":"2021-07-29","type":"trial","source":"PR Newswire","summary":"Evogene to Present at Jefferies Virtual Industrials Conference, 2021 - PR Newswire","headline":"Evogene to Present at Jefferies Virtual Industrials Conference, 2021","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}